Sign In
26 Jun 2018 16:24
("NetScientific" or the "Company" or the "Group")
NetScientific plc
Grant of Options to Directors
London, UK - 26th June 2018 - NetScientific plc (AIM:NSCI) (the "Company"), the transatlantic healthcare IP commercialisation Group, today announced that on 21st June 2018, options over ordinary shares of 5p each were granted to its CEO François Martelet and CFO Ian Postlethwaite as detailed below (the "New Options").
Director | Number of Options Granted | Total Number of Options Held |
Francois Martelet | 300,000 | 1,059,020 |
Ian Postlethwaite | 200,000 | 560,000 |
The New Options have an exercise price of 45.5 pence per share, being the average closing price for the ordinary shares over the five dealing days prior to the date on which the options were granted. The New Options vest three years from the date of grant.
For more information, please contact:
NetScientific François R. Martelet, M.D., CEO Ian Postlethwaite, CFO
| Tel: +44 (0)20 3514 1800 |
Consilium Strategic Communications Mary-Jane Elliott Jessica Hodgson / Chris Welsh / Laura Thornton
| Tel: +44 (0)20 3709 5700 netscientific@consilium-comms.com |
Stifel Nicolaus Europe Limited (NOMAD and Broker) Jonathan Senior / David Arch / Ben Maddison
| Tel: +44 (0) 20 7710 7600 |
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the grant of options to PDMRs.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Francois Martelet | ||||
2 | Reason for the notification | |||||
a) | Position/status | CEO, NetScientific plc | ||||
b) | Initial notification/ Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | NetScientific plc | ||||
b) | LEI | 213800N5WD46G1Y7I458 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code |
Option over Ordinary Shares
ISIN for NetScientific plc Ordinary Shares: GB00B9F4MT28
| ||||
b) | Nature of the transaction | Grant of option | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
300,000 £0.455 | ||||
e) | Date of the transaction | 21 June 2018 | ||||
f) | Place of the transaction | Off market | ||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Ian Postlethwaite | ||||
2 | Reason for the notification | |||||
a) | Position/status | CFO, NetScientific plc | ||||
b) | Initial notification/ Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | NetScientific plc | ||||
b) | LEI | 213800N5WD46G1Y7I458 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code |
Option over Ordinary Shares
ISIN for NetScientific plc Ordinary Shares: GB00B9F4MT28
| ||||
b) | Nature of the transaction | Grant of option | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
200,000 £0.455 | ||||
e) | Date of the transaction | 21 June 2018 | ||||
f) | Place of the transaction | Off market | ||||
About NetScientific
NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net
Follow the stocks
